Caveat Emptor: Direct-to-Consumer Supply and Advertising of Genetic TestingClinical and Investigative Medicine. Volume 27, Number 1 (2004), p. 23-32.
- DTC advertising,
- DTC campaign by Myriad,
- genetic testing,
- health law,
- private access,
- regulatory system
AbstractThis article has 4 intents: 1. to highlight the major players and targeted consumers in the realm of private access to genetic testing and DTC advertising. 2. to canvass arguments for and against private access to commercially available genetic testing. 3. to analyze the recent DTC campaign by Myriad as an example of what may be on the horizon for Canada. 4. to question the adequacy of Canada's current regulatory system to deal with advertisements of this nature and, by examining the routes taken in other jurisdictions, to explore the potential for an improved regulatory framework specific to genetic testing services.
Creative Commons LicenseCreative Commons Attribution-Noncommercial-No Derivative Works 4.0
Citation InformationMykitiuk, Roxanne. "Caveat Emptor: Direct-to-Consumer Supply and Advertising of Genetic Testing." Clinical and Investigative Medicine 27.1 (2004): 23-32.